IRadimed Corporation

NASDAQ: IRMD · Real-Time Price · USD
70.32
0.17 (0.24%)
At close: Aug 15, 2025, 12:42 PM

IRadimed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
77.64M 75.15M 73.24M 71.31M 69.48M 67.69M 65.56M 62.97M 59.88M 56.47M 53.3M 50.31M 47.81M 44.9M 41.81M 38.49M 35.28M 32.26M
Cost of Revenue
17.88M 17.35M 16.89M 16.3M 15.84M 15.86M 15.4M 15.01M 14.21M 12.84M 12.02M 11M 10.64M 10.53M 9.76M 9.25M 8.7M 8.09M
Gross Profit
59.75M 57.8M 56.35M 55M 53.65M 51.82M 50.16M 47.97M 45.67M 43.62M 41.28M 39.31M 37.17M 34.37M 32.05M 29.24M 26.58M 24.17M
Operating Income
23.81M 22.65M 21.96M 21.32M 21.44M 20.78M 20.04M 19.13M 17.36M 16.56M 15.63M 14.48M 13.44M 11.12M 9.82M 7.36M 5.06M 283.68K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
26.04M 24.98M 24.28M 23.61M 23.6M 22.63M 21.74M 20.76M 18.59M 17.47M 16.18M 14.59M 13.45M 11.12M 9.84M 7.39M 5.09M 318.73K
Net Income
20.66M 19.78M 19.23M 18.63M 18.64M 17.92M 17.19M 16.33M 14.69M 13.75M 12.83M 13.05M 12.2M 10.43M 9.33M 6.07M 4.57M 986.64K
Selling & General & Admin
33.23M 32.52M 31.55M 30.77M 29.48M 28.16M 27.26M 26.02M 25.46M 24.51M 23.38M 22.66M 21.58M 21.3M 20.33M 19.96M 19.6M 21.94M
Research & Development
2.71M 2.63M 5.84M 5.92M 5.73M 5.89M 2.86M 2.81M 2.85M 2.55M 2.28M 2.17M 2.16M 1.95M 1.91M 1.92M 1.92M 1.95M
Other Expenses
n/a n/a 495.15K 495.15K 495.15K 495.15K n/a n/a n/a 13.1K -1.81K 2.12K 9.26K 9.35K 18.61K 28.18K 30.39K 35.05K
Operating Expenses
35.94M 35.16M 34.39M 33.68M 32.21M 31.05M 30.12M 28.84M 28.31M 27.06M 25.65M 24.83M 23.74M 23.25M 22.23M 21.88M 21.52M 23.89M
Interest Expense
n/a n/a n/a 342.41K 342.41K 342.41K 342.41K n/a n/a n/a 14.91K 14.91K 14.91K 14.91K n/a n/a n/a n/a
Selling & Marketing Expenses
16.5M 15.97M 15.62M 14.43M 13.5M 12.8M 11.97M 12.31M 12.48M 12.61M 12.68M 12.14M 11.68M 11.25M 10.56M 10.5M 10.2M 10.1M
Cost & Expenses
53.83M 52.51M 51.28M 49.98M 48.04M 46.91M 45.53M 43.84M 42.52M 39.91M 37.68M 35.83M 34.37M 33.79M 32M 31.13M 30.22M 31.98M
Income Tax Expense
5.38M 5.19M 5.04M 4.99M 4.96M 4.71M 4.55M 4.43M 3.9M 3.72M 3.35M 1.54M 1.25M 699.62K 510.82K 1.32M 518.8K -667.91K
Shares Outstanding (Basic)
12.72M 12.71M 12.68M 12.67M 12.66M 12.66M 12.62M 12.6M 12.6M 12.62M 12.57M 12.56M 12.56M 12.55M 12.43M 12.33M 12.31M 12.31M
Shares Outstanding (Diluted)
12.83M 12.83M 12.78M 12.78M 12.76M 12.75M 12.74M 12.74M 12.72M 12.69M 12.63M 12.63M 12.63M 12.66M 12.63M 12.6M 12.55M 12.52M
EPS (Basic)
1.63 1.57 1.53 1.48 1.48 1.42 1.36 1.29 1.16 1.09 1.02 1.04 0.98 0.84 0.75 0.49 0.37 0.08
EPS (Diluted)
1.62 1.55 1.50 1.46 1.46 1.41 1.36 1.29 1.16 1.09 1.02 1.04 0.97 0.83 0.74 0.48 0.37 0.08
EBITDA
24.74M 23.58M 23.42M 22.77M 22.89M 22.41M 21.13M 19.67M 18.33M 17.84M 17.16M 16.23M 15.09M 12.62M 11.22M 8.72M 6.41M 1.61M
EBIT
16.4M 22.67M 21.96M 22.98M 23.6M 22.63M 21.4M 19.97M 17.8M 16.68M 15.73M 14.59M 13.45M 11.12M 9.84M 7.39M 5.09M 300.88K
Depreciation & Amortization
586.56K 785.69K 817.66K 828.17K 820.43K 808.65K 765.12K 734.55K 712.35K 693.1K 670.67K 657.11K 646.28K 640.88K 634.01K 811.77K 985.96K 1.15M